D006339DisordersPhysiologyE01.370.600.875.500G09.330.380.50024370.979844Heart RateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDivision of ResearchDepartment of Research and EvaluationKaiser Permanente GeorgiaKaiser Permanente Northern CaliforniaKaiser Permanente Southern CaliforniaDeborahYoungDeborah Rohm Young, PhD, MBA34.14383190000000-118.14096620000000100Young, Deborah0000-0002-8335-7851Director, Division of Behavioral ResearchAlanGoAlan S. Go, MD37.80931810000000-122.26769880000000148Go, Alan0000-0001-9109-0811Associate Director, Cardiovascular and Metabolic Conditions26691637Jones SM, Guthrie KA, LaCroix AZ, Sternfeld B, Landis CA, Reed SD, Dunn A, Caan B, Cohen LS, Hunt J, Newton KMClinical autonomic research : official journal of the Clinical Autonomic Research SocietyIs heart rate variability associated with frequency and intensity of vasomotor symptoms among healthy perimenopausal and postmenopausal women? Clin Auton Res. 2016 Feb; 26(1):7-13.Clin Auton Res2015-12-21T00:00:002015Is heart rate variability associated with frequency and intensity of vasomotor symptoms among healthy perimenopausal and postmenopausal women?25524354Hlatky MA, Andersson C, Chang TI, Kazi D, Solomon MD, Go ASJournal of the American College of CardiologyReply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients. J Am Coll Cardiol. 2014 Dec 23; 64(24):2712.J Am Coll Cardiol2014-12-23T00:00:002014Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients.Kaiser Permanente Northwest3Assistant Investigator / Research Scientist I1Senior Investigator / Research Scientist IIIMaryMcBurnieMary Ann McBurnie, PhD45.54734220000000-122.6817828000000043McBurnie, Mary0000-0003-0314-220XDistinguished InvestigatorCenter for Health ResearchCenter for Research and Evaluation26410158Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJThe Annals of thoracic surgeryHeart Rate Recovery as a Preoperative Test of Perioperative Complication Risk. Ann Thorac Surg. 2015 Nov; 100(5):1954-62.Ann Thorac Surg2015-09-26T00:00:002015Heart Rate Recovery as a Preoperative Test of Perioperative Complication Risk.0.7545260.005369724research area of0.7300490.018426463subject area for31376471Ha D, Malhotra A, Ries AL, O'Neal WT, Fuster MMRespiratory physiology & neurobiologyHeart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure. Respir Physiol Neurobiol. 2019 11; 269:103264.Respir Physiol Neurobiol2019-07-31T00:00:002019Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure.28521892Bhatt AS, DeVore AD, DeWald TA, Swedberg K, Mentz RJJournal of the American College of CardiologyAchieving a Maximally Tolerated ß-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? J Am Coll Cardiol. 2017 May 23; 69(20):2542-2550.J Am Coll Cardiol2017-05-23T00:00:002017Achieving a Maximally Tolerated ß-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?AnkeetBhattAnkeet Bhatt, MD284Bhatt, AnkeetResearch Scientist IA.RyersonA. Blythe Ryerson, PhD, MPH285Ryerson, A.Executive Directortrue1Distinguished InvestigatorDistinguished Investigatortrue1Executive DirectorExecutive Directortrue1Director, Division of Behavioral ResearchDirector, Division of Behavioral Researchtrue1Research Scientist IResearch Scientist Itrue1Associate Director, Cardiovascular and Metabolic ConditionsAssociate Director, Cardiovascular and Metabolic Conditions